David brings 30 years of experience in the biopharmaceutical industry, and has served as:
- Chair of the PhRMA Law Section.
- The global head lawyer at Bristol-Myers Squibb in three different practice areas: Regulatory Law, Transactions and Intellectual Property.
- A member of the BMS Research & Development Executive Committee for over 10 years.
- The leader of multifunctional teams that handled high profile projects in areas such as intellectual property strategy/exclusivity challenges, scientific integrity investigations, complex orphan drug and pediatric research matters, management of the fallout from negative drug safety findings and the reassessment of a major company’s approach to risk and control.